Sexual Dimorphism in Outcomes of Non–muscle-invasive Bladder Cancer: A Role of CD163+ Macrophages, B cells, and PD-L1 Immune Checkpoint
Open Access
- 1 July 2021
- journal article
- research article
- Published by Elsevier BV in European Urology Open Science
- Vol. 29, 50-58
- https://doi.org/10.1016/j.euros.2021.05.002
Abstract
No abstract availableKeywords
Funding Information
- Queen's University
- SEAMO
- Ontario Ministry of Research and Innovation
This publication has 43 references indexed in Scilit:
- The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part B: Prostate and Bladder TumoursEuropean Urology, 2016
- Macrophages Subvert Adaptive Immunity to Urinary Tract InfectionPLoS Pathogens, 2015
- Tumor associated macrophages polarization dictates the efficacy of BCG instillation in non-muscle invasive urothelial bladder cancerJournal of Experimental & Clinical Cancer Research, 2013
- Female gender is associated with higher risk of disease recurrence in patients with primary T1 high-grade urothelial carcinoma of the bladderWorld Journal of Urology, 2012
- Defect in regulatory B-cell function and development of systemic autoimmunity in T-cell Ig mucin 1 (Tim-1) mucin domain-mutant miceProceedings of the National Academy of Sciences of the United States of America, 2012
- B cells and macrophages in cancer: yin and yangNature Medicine, 2011
- Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor κBProceedings of the National Academy of Sciences of the United States of America, 2009
- Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC TrialsEuropean Urology, 2006
- The chemokine system in diverse forms of macrophage activation and polarizationTrends in Immunology, 2004
- Survival plots of time-to-event outcomes in clinical trials: good practice and pitfallsThe Lancet, 2002